The MYC network and cancer

Signaling Pathways in Liver Diseases

Volumn , Issue , 2010, Pages 359-365

  Thorgeirsson, Snorri S ^a   Factor, Valentina M ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84891418527     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-642-00150-5_24     Document Type: Chapter

References (55)

1. Nesbit CE, Tersak JM, Prochownik EV (1999) MYC oncogenes and human neoplastic disease. Oncogene 18:3004-3016
2. Dang CV (1999) c-Myc target genes involved in cell growth, apoptosis, and metabolism. Mol Cell Biol 19:1-11
3. Pelengaris S, Khan M, Evan G (2002) c-MYC: more than just a matter of life and death. Nat Rev Cancer 2:764-776
4. Adhikary S, Eilers M (2005) Transcriptional regulation and transformation by Myc proteins. Nat Rev Mol Cell Biol 6:635-645
5. Bishop JM (1982) Retroviruses and cancer genes. In: George Kline SW (ed) Advances in cancer research, 37. Academic Press Inc., New York, pp 1-32
6. Dang CV, O'Donnell KA, Zeller KI et al (2006) The c-Myc target gene network. Semin Cancer Biol 16:253-264
7. Oster SK, Ho CS, Soucie EL et al (2002) The MYC oncogene: marvelously complex. Adv Cancer Res 84:81-154
8. Alitalo K, Schwab M (1986) Oncogene amplification in tumor cells. Adv Cancer Res 47:235-281
9. Meyer N, Penn LZ (2008) Reflecting on 25 years with MYC. Nat Rev Cancer 8:976-990
10. Eilers M, Eisenman RN (2008) Myc's broad reach. Genes Dev 22:2755-2766
11. Secombe J, Pierce SB, Eisenman RN (2004) Myc: a weapon of mass destruction. Cell 117:153-156
12. Eisenman RN (2001) Deconstructing myc. Genes Dev 15:2023-2030
13. Lau LF, Nathans D (1987) Expression of a set of growthrelated immediate early genes in BALB/c 3 T3 cells: coordinate regulation with c-fos or c-myc. Proc Natl Acad Sci U S A 84:1182-1186
14. Lanahan A, Williams JB, Sanders LK et al (1992) Growth factor induced delayed early response genes. Mol Cell Biol 12:3919-3929
15. Kim SY, Herbst A, Tworkowski KA et al (2003) Skp2 regulates Myc protein stability and activity. Mol Cell 11:1177-1188
16. Salghetti SE, Kim SY, Tansey WP (1999) Destruction of Myc by ubiquitinmediated proteolysis: cancer-associated and transforming mutations stabilize Myc. EMBO J 18:717-726
17. Lutterbach B, Hann SR (1999) c-Myc transactivation domain-associated kinases: questionable role for map kinases in c-Myc phosphorylation. J Cell Biochem 72:483-491
18. Lutterbach B, Hann SR (1994) Hierarchical phosphorylation at N-terminal transformation-sensitive sites in c-Myc protein is regulated by mitogens and in mitosis. Mol Cell Biol 14:5510-5522
19. Sears R, Leone G, DeGregori J et al (1999) Ras enhances Myc protein stability. Mol Cell 3:169-179
20. Yeh E, Cunningham M, Arnold H et al (2004) A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells. Nat Cell Biol 6:308-318
21. Sakamuro D, Prendergast GC (1999) New Myc-interacting proteins: a second Myc network emerges. Oncogene 18:2942-2954
22. Sakamuro D, Elliott KJ, Wechsler-Reya R et al (1996) BIN1 is a Novel MYC-interacting protein with features of a tumour suppressor. Nat Genet 14:69-77
23. Eilers M, Picard D, Yamamoto KR et al (1989) Chimaeras of myc oncoprotein and steroid receptors cause hormonedependent transformation of cells. Nature 340:66-68
24. Eberhardy SR, Farnham PJ (2001) c-Myc mediates activation of the cad promoter via a post-RNApolymerase II recruitment mechanism. J Biol Chem 276:48562-48571
25. Zeller KI, Haggerty TJ, Barrett JF et al (2001) Characterization of nucleophosmin (B23) as a Myc target by scanning chromatin immunoprecipitation. J Biol Chem 76:48285-48291
26. Mao DY, Watson JD, Yan PS et al (2003) Analysis of Myc bound loci identified by CpG island arrays shows that Max is essential for Myc-dependent repression. Curr Biol 13:882-886
27. Haggerty TJ, Zeller KI, Osthus RC et al (2003) A strategy for identifying transcription factor binding sites reveals two classes of genomic c-Myc target sites. Proc Natl Acad Sci U S A 100:5313-5318
28. Coller HA, Grandori C, Tamayo P et al (2000) Expression analysis with oligonucleotide microarrays reveals that MYC regulates genes involved in growth, cell cycle, signaling, and adhesion. Proc Natl Acad Sci U S A 97:3260-3265
29. Guo QM, Malek RL, Kim S et al (2000) Identification of c-myc responsive genes using rat cDNA microarray. Cancer Res 60:5922-5928
30. Schuldiner O, Benvenisty N (2001) A DNA microarray screen for genes involved in c-MYC and N-MYC oncogenesis in human tumors. Oncogene 20:4984-4994
31. Marinkovic D, Marinkovic T, Kokai E et al (2004) Identification of novel Myc target genes with a potential role in lymphomagenesis. Nucleic Acids Res 32:5368-5378
32. Lawlor ER, Soucek L, Brown-Swigart L et al (2006) Reversible kinetic analysis of Myc targets in vivo provides novel insights into Myc-mediated tumorigenesis. Cancer Res 66:4591-4601
33. O'Connell BC, Cheung AF, Simkevich CP et al (2003) A large scale genetic analysis of c-Myc-regulated gene expression patterns. J Biol Chem 278:12563-12573
34. Ellwood-Yen K, Graeber TG, Wongvipat J et al (2003) Mycdriven murine prostate cancer shares molecular features with human prostate tumors. Cancer Cell 4:223-238
35. Lee JS, Chu IS, Mikaelyan A et al (2004) Application of comparative functional genomics to identify best-fit mouse models to study human cancer. Nat Genet 36:1306-1311
36. Wu CH, Sahoo D, Arvanitis C et al (2008) Combined analysis of murine and human microarrays and ChIP analysis reveals genes associated with the ability of MYC to maintain tumorigenesis. PLoS Genet 4:1-16
37. Sahoo D, Dill DL, Tibshirani R et al (2007) Extracting binary signals from microarray time-course data. Nucleic Acids Res 35:3705-3712
38. Liu J, Levens D (2006) Making myc. Curr Top Microbiol Immunol 302:1-32
39. Rabbitts PH, Watson JV, Lamond A et al (1985) Metabolism of c-myc gene products: c-myc mRNA and protein expression in the cell cycle. EMBO J 4:2009-2015
40. Ramsay G, Evan GI, Bishop JM (1984) The protein encoded by the human proto-oncogene c-myc. Proc Natl Acad Sci U S A 81:7742-7746
41. Popescu NC, Zimonjic DB (2002) Chromosome-mediated alterations of the MYC gene in human cancer. J Cell Mol Med 6:151-159
42. Spencer CA, Groudine M (1991) Control of c-myc regulation in normal and neoplastic cells. Adv. Cancer Res 56:1-48
43. Sears R, Leone G, DeGregori J et al (1999) Ras enhances Myc protein stability. Mol Cell 3:169-79
44. He TC, Sparks AB, Rago C et al (1998) Identification of c-MYC as a target of the APC pathway. Science 281:1509-12
45. Kolligs FT, Bommer G, Goke B (2002) Wnt/beta-catenin/tcf signaling: a critical pathway in gastrointestinal tumorigenesis. Digestion 66:131-144
46. Evan G, Littlewood T (1998) A matter of life and cell death. Science 281:1317-1322
47. Lowe SW, Cepero E, Evan G (2004) Intrinsic tumour suppression. Nature 432:307-315
48. Eischen CM, Weber JD, Roussel MF et al (1999) Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Mycinduced lymphomagenesis. Genes Dev 13:2658-2669
49. Kamijo T, Weber JD, Zambetti G et al (1998) Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2. Proc Natl Acad Sci U S A 95:8292-8297
50. Schmitt CA, McCurrach ME, de Stanchina E et al (1999) INK4a/ARF mutations accelerate lymphomagenesis and promote chemoresistance by disabling p53. Genes Dev 13:2670-2677
51. Zindy F, Eischen CM, Randle DH et al (1998) Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization. Genes Dev 12:2424-2433
52. Askew DS, Ashmun RA, Simmons BC et al (1991) Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis. Oncogene 6:1915-1922
53. Evan GI, Wyllie AH, Gilbert CS et al (1992) Induction of apoptosis in fibroblasts by c-myc protein. Cell 69:119-128
54. Murphy DJ, Junttila MR, Pouyet L et al (2008) Distinct thresholds govern Myc's biological output in vivo. Cancer Cell 14:447-457
55. Freie BW, Eisenman RN (2008) Ratcheting Myc. Cancer Cell 14:425-426